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 Shining the light on eating disorders, incidence,
prognosis and profiling of patients in primary and
secondary care: national data linkage study
Joanne C. Demmler, Sinead T. Brophy, Amanda Marchant, Ann John and Jacinta O. A. Tan
Background
Diagnosing eating disorders can be difficult and few people with
the disorder receive specialist services despite the associated
high morbidity and mortality.
Aims
To examine the burden of eating disorders in the population in
terms of incidence, comorbidities and survival.
Method
We used linked electronic health records from general practi-
tioner and hospital admissions in Wales, UK within the Secure
Anonymised Information Linkage (SAIL) databank to investigate
the incidence of new eating disorder diagnoses. We examined
the frequency of comorbid diagnoses and prescribed medica-
tions in cases and controls in the 2 years before and 3 years after
diagnosis, and performed a survival analysis.
Results
A total of 15 558 people were diagnosed with eating disorders
between 1990 and 2017. The incidence peaked at 24 per 100 000
people in 2003/04. People with eating disorders showed higher
levels of other mental disorders (odds ratio 4.32, 95% CI 4.01–
4.66) and external causes of morbidity and mortality (odds ratio
2.92, 95% CI 2.44–3.50). They had greater prescription of central
nervous system drugs (odds ratio 3.15, 95% CI 2.97–3.33),
gastrointestinal drugs (odds ratio 2.61, 95% CI 2.45–2.79) and
dietetic drugs (odds ratio 2.42, 95% CI 2.24–2.62) before diagno-
sis. These excess diagnoses and prescriptions remained 3 years
after diagnosis. Mortality was raised compared with controls for
some eating disorders, particularly in females with anorexia
nervosa.
Conclusions
Incidence of diagnosed eating disorders is relatively low in the
population but there is a major longer term burden in morbidity
and mortality to the individual.
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Eating disorders have high morbidity and the highest mortality of
all mental disorders,1,2 yet they can be difficult to diagnose. They
are characterised by disturbed eating behaviour associated with
concern about weight and shape. People with eating disorders are
often young and highly vulnerable yet ambivalent about recovery
and may be difficult to engage with treatment.3,4 Without specific
knowledge of the condition, people with this mental health condi-
tion can evade detection, thus delaying time to diagnosis and treat-
ment and influencing long-term outcome. Carers for people with
eating disorders experience high levels of strain.5 Healthcare costs
for eating disorders in the National Health Service (NHS) across
the UK have been recently estimated as £3.9–4.6 billion with an
overall economic cost likely to be more than £6.8–8 billion per
year.6 Over 1.6 million people in the UK are estimated to be affected
by eating disorders, and this is likely to be an underestimate as many
people do not seek help.7 In addition, it is reported that the number
of people diagnosed with eating disorders has increased by 15%
between 2000 and 2009,8 and it is not clear if this is due to increased
help seeking or due to better diagnosis. Generally, across the UK
there have historically been relatively scarce and variable resources
for eating disorders.9 Given the difficulty of engaging people with
eating disorders in treatment and the scarcity of resource provision
for such specialist treatment, it is likely that specialist eating
disorder treatment teams see a minority of those – whether child,
adolescent or adult – with the disorder. General practitioners
(GPs; or family physicians, in this article we will refer to them as
‘primary care’) must identify and diagnose eating disorders in
patients before they can be referred to specialist services (which
we call ‘secondary care’) and, in many cases and for a variety of
reasons, patients may only be known to, or receive treatment in,
primary care. There has been previous routine clinical databank
work in the UK of incidence,8 and previous work on mortality of
eating disorders.10 This is the first article in the UK to examine
the burden of eating disorders including the incidence, survival
and characteristics of those with eating disorders both before and
after their diagnosis.
Methods
Study design: record-linked electronic cohort study
The linkage and hosting of data were performed in the Secure
Anonymised Information Linkage (SAIL) databank.11–15 The
SAIL databank is a large routine clinical database covering the
whole of Wales. Anonymised record linkage is carried out in the
SAIL databank on routinely collected data held in health and
social care data sets and supported by the national institute for
Health Data Research UK (HDR UK; https://www.hdruk.ac.uk).
For each data set within the SAIL databank, individuals’ identities
are removed and replaced with an Anonymised Linking Field
(ALF), based on their names, address or NHS number, which is
used to link across data sets. All data within the SAIL Gateway
are treated in accordance with the Data Protection Act 2018 and
is compliant with the General Data Protection Regulation.
Appropriate disclosure control methods were used to restrict the
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reporting of small numbers (i.e. categories containing less than five
individuals).
We used data from a variety of data sets between 1 July 1990 and
30 June 2017 (start and end of primary care data) which were placed
in SAIL by the Welsh NHS and other data holders. The GP data
covers, at the time of writing, 77% of all GP practices in Wales.
The Welsh Demographics Service (WDS) contains key statistics –
such as gender, week of birth and date of death – for everyone in
Wales registered with a GP. The Patient Episode Database for
Wales (PEDW) contains all in-patient hospital admissions to
Welsh hospitals. The Office of National Statistics (ONS) data set
covers all births and deaths in Wales. The ONS, WDS and PEDW
data are available for the whole of Wales.
Data preparation
We verified individuals with a diagnosis of an eating disorder using
Read Version 216 diagnosis codes in primary care data (visits to
family physician) and ICD-10 (1992) diagnosis codes17 in second-
ary care data (hospital admissions) between the ages of 10 and 65
years. The date of first mention of eating disorder (from GP or hos-
pital data) was used for each individual, so a diagnosis is only
recorded once for each person. The use of the ALF unique to each
individual ensures that individuals are not double counted when
they appear in both GP and secondary care data. Only individuals
with either an exact match on NHS number or demographics, or
a probabilistic match of over 90% were included in this study.
Eating disorders were divided into three groups, i.e. (a) anorexia
nervosa, (b) bulimia nervosa and (c) other eating disorders, using
a hierarchical system. The clinical codes used in Read Version 2
can be found in Supplementary Table 1, available at https://doi.
org/10.1192/bjp.2019.153; those for ICD-10 are in Supplementary
Table 2.
To be included in the cohort, individuals needed to have been
correctly matched to the WDS (i.e. had an ALF) and have a week
of birth and gender recorded. If there were multiple diagnoses
codes and dates, we kept the earliest diagnosis date and the top diag-
nosis category (i.e. ‘anorexia nervosa’ in preference to ‘bulimia
nervosa’ and ‘bulimia nervosa’ in preference to ‘other eating disor-
ders’, which encompassed all other eating disorder diagnoses). We
finally created a combined cohort of anyone with an eating disorder
diagnosis in either the GP or hospital admissions data, using the
same hierarchical rules.
The Read codes were validated using the methodology
employed by the Health Informatics Trial Enhancement Project.18
This methodology has proved both secure and effective in validating
mental health algorithms with the SAIL databank. Two independent
mental health clinicians were given secure access to this data set to
rate eligibility for inclusion in the ‘e-cohort’. This method is particu-
larly advantageous in allowing sensitivity and specificity to be calcu-
lated by using clinical judgement as the gold standard with no risk of
participant identification. A kappa statistic was obtained to measure
the agreement between the two clinicians, an eating disorder psych-
iatrist and a GP with mental health expertise. The kappa value was
0.82, showing a high level of agreement. Analysis was conducted
using SPSS version 20 for Windows.
Analysis
Data linkage and data preparation within the SAIL databank for
Windows 7 Enterprise were conducted using IBM DB2 9.7 SQL.
Data were then imported into R (version 3.4.1), which was used
for most statistical analyses. Survival analysis was executed in
Stata 15. Results from primary and secondary care extracts were
combined to create a joined eating disorder cohort.
Incidence
The denominator of the diagnosed incidence of eating disorders in
secondary care was calculated based on the total number of indivi-
duals with recorded gender, registered and living in Wales between
1 July 1990 and 30 June 2017 for each full year of the study, respect-
ively. The primary care denominator was further adjusted to include
only people living inWales and whose GP practice was contributing
data to SAIL. The incidence in primary and secondary care was
then added together to create an overall estimate of the incidence
in Wales. Descriptive statistics were used to examine the age and
year of first diagnosis, stratified by eating disorder type.
A Student’s t-test was used to investigate the difference in the
mean age of diagnosis by diagnosis type and age.
Characteristics of patient before and after diagnosis,
stratified by eating disorder type
People diagnosed with an eating disorder were matched on gender
and age at diagnosis with four controls per patient with an eating
disorder, using a computer algorithm. Randomisation was used if
there were multiple potential matches with equal distance. Both
patients and controls were required to have 2 years of GP data
before (cohort 1) or 3 years of GP data after (cohort 2) diagnosis/
matching date. (Results for a much smaller single case–control
cohort spanning all 5 years were added for comparison in
Supplementary Fig. 7.) The period of available data at each GP prac-
tice was defined as the period when the practice was recording a suf-
ficient volume of events, and was therefore believed to be regularly
coding data in an electronic system. The volume of events over time
was defined as Read-coded events per person-month, and periods of
time where the volume was at least 10% as high as 2009 (a known
good period of data) were included. Patients with less than four con-
trols were excluded, i.e. each patient had exactly four controls. We
examined the frequency of codes in Read chapters ‘A–Z’ (diagnoses)
and ‘a–z’ (prescriptions) in the 2 years before a diagnosis compared
with controls, and separately in the 3 years after diagnosis. The odd
ratios of a diagnosis/prescription were calculated for all Read chap-
ters and Read sections or subsections of interest. We used this
method as a means to profile anything that might be of importance
to people with eating disorders instead of concentrating on codes
that are known to be of importance.
Survival analysis
Cox regression and Kaplan–Meier estimates were used to examine
time to death stratified by eating disorder type, compared with con-
trols. Data were censored if a person moved out of Wales or moved
to a GP that did not return data to SAIL. Patients whomove between
GPs who contribute to SAIL (80% of all practices in Wales) can be
linked across GP practices.
Ethical approval
The study design uses anonymised data and therefore the need
for ethical approval and participant consent was waived by the
approving Institutional Review Board, UK NHS Research Ethics
Committee. The SAIL independent Information Governance
Review Panel (IGRP), which contains members from the UK
NHS Research Ethics Committee, experts in information govern-
ance and members of the public, approved the study.
Data sharing
The data used in this study are available in the SAIL databank at
Swansea University, Swansea, UK. All proposals to use SAIL data
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are subject to review by an independent IGRP. Before any data can
be accessed, approval must be given by the IGRP.
The IGRP gives careful consideration to each project to ensure
proper and appropriate use of SAIL data. When access has been
granted, it is gained through a privacy-protecting safe haven and
remote access system referred to as the SAIL Gateway. SAIL has
established an application process to be followed by anyone who
would like to access data via SAIL: https://www.saildatabank.com/
application-process.
Results
Eating disorders in GP data
The GP data contained a total of 14 304 individuals aged between 10
and 65 years that had been diagnosed with an eating disorder
between 1990/91 and 2016/17. Anorexia nervosa was diagnosed in
4128 individuals, bulimia nervosa in 4584 individuals and other
eating disorders in 5364 individuals (see Fig. 1 GP data).
The age at first recorded diagnosis peaked in the age group 15–
19 years for both genders (see Supplementary Fig. 1). The median
age at diagnosis with any eating disorder was 20. Anorexia
nervosa and other eating disorders were diagnosed earlier than
bulimia nervosa. There was a statistically significant difference in
the age of diagnosis between men and women with anorexia
(male 25 years, female 22 years; 95% CI 1.22–4.25) and bulimia
nervosa (male 27 years, female 25 years; 95% CI 0.78–3.45), with
males being diagnosed later than females.
The mean number of new diagnoses (incidence) per GP practice
in each year ranged from 1.6 to 3.0 per practice size of 11 500
patients with its peak in 2004/05. The maximum number of cases
(prevalence) in a single GP practice was 26.
Incidence over time
The incidence of diagnosed eating disorders in the Welsh
population (taken from GP and hospital data) ranged from 8 per
100 000 people in 1990/91 to 24 per 100 000 people at its
maximum in 2003/04 (see Fig. 2). Although coded diagnoses of
eating disorders in GP practices have declined slightly since 2008,
referrals by GPs to specialist eating disorders clinics has progres-
sively increased since 2000. In addition, hospital admissions with
eating disorders have also continued to rise (see Fig. 2). However,
in general, the majority of eating disorders are not referred or
found in hospital (see Fig. 1).
Characteristics of people with eating disorders
A total of 15 558 (male 1363, female 14 195) had a diagnosis of an
eating disorder in either primary or secondary health records.
A total of 6560 patients with eating disorders (42.2% of the total)
had continuous GP records in the SAIL databank and could be
matched to 4 controls for 2 years before their eating disorder diag-
nosis. Similarly, 5777 patients with eating disorders (37.1% of the
total) had continuous GP records in the SAIL databank and could
be matched to 4 controls for 3 years after their eating disorder diag-
nosis (see Fig. 1). The main reason for the loss of patients were
migration (i.e. people were not registered with a GP in SAIL for
the whole 5-year follow-up period) and GP data coverage (i.e.
years of low data volume for individual GP practices).
Significant differences in diagnosis and prescription codes
between patients and controls before and after diagnosis are
shown in Fig. 3. Those with eating disorders showed higher levels
of mental disorders (odds ratio 4.32, 95% CI 4.01–4.66) and external
causes of morbidity and mortality, for instance self-harm (odds
ratio 2.92, 95% CI 2.44–3.50) before their diagnosis. The largest
odds ratios for mental disorders before diagnosis were found for
personality disorders (odds ratio 10.82, 95% CI 6.58–18.56),
alcohol dependence syndrome (odds ratio 6.03, 95% CI 3.92–9.40)
and depressive disorders (odds ratio 5.93, 95% CI 4.78–7.37). All
statistically significant mental health results can be found in
Supplementary Fig. 2.
Central nervous system drugs (including psychiatric drugs)
(odds ratio 3.15, 95% CI 2.97–3.33), gastrointestinal drugs (odds
ratio 2.61, 95% CI 2.45–2.79) and dietetic drugs (odds ratio 2.42,
95% CI 2.24–2.62) were more often prescribed in the patients
with eating disorders in the 2 years before their diagnosis then in
the controls. Prescription levels differ between young people and
adults (see Supplementary Fig. 6).
The most relevant central nervous system drugs prescribed
before diagnosis where antipsychotics (odds ratio 6.78, 95% CI
5.48–8.40), tricyclic antidepressants (odds ratio 3.73, 95% CI
3.28–4.24), other antidepressants (odds ratio 5.24, 95% CI 4.87–
5.64), hypnotics (odds ratio 4.31, 95% CI 3.79–4.90) and anxiolytics
(odds ratio 4.05, 95% CI 3.58 anxiolytics 4.59) (see also
Supplementary Fig. 3).
People with eating disorders also showed a high amount of
gastrointestinal drug prescriptions (see Supplementary Fig. 4) and
exhibited much higher levels of dietetic supplement prescriptions
(odds ratio 19.01, 95% CI 14.59–25.16), multivitamin preparations
(odds ratio 8.37, 95% CI 5.82–12.22) and other preparations (see
Supplementary Fig. 5).
Survival
Deaths occurred across a wide time span from when the eating dis-
order diagnosis was first made within SAIL, with 6% of patients with
anorexia nervosa dying within 15 years of diagnosis. Patients with
anorexia nervosa were significantly more likely to die than their
controls (hazard ratio 2.33, 95% CI 1.95–2.78). This was particularly
evident for females with anorexia nervosa (hazard ratio 2.53, 95%CI
2.09–3.05). Slightly higher mortality was also found in bulimia
nervosa (hazard ratio 1.41, 95% CI 1.13–1.779) and in other
eating disorders (hazard ratio 1.82, 95% CI 1.53–2.18), see also
Table 1.
The leading type of cause of death in the eating disorder cohort
was diseases of the respiratory system (17.9% of deaths; includes
bronchopneumonia, pneumonia, chronic obstructive pulmonary
disease, pneumonitis due to food and vomit, and respiratory
failure), followed by injury, poisoning and certain other conse-
quences of external causes (13.3% of deaths; includes poisoning,
asphyxiation) and diseases of the digestive system (11.4% of
deaths; includes gastrointestinal haemorrhage, alcohol related,
hepatic failure, hepatorenal syndrome, cirrhosis of liver). In the
eating disorder cohort, 82% of deaths had an assigned cause of
death. In contrast, the leading cause of death for the control
cohort was neoplasms (17.9% of deaths), followed by diseases of
the circulatory system (10.1%; includes heart diseases, stroke) and
diseases of the respiratory system (8.0% of deaths; includes bron-
chopneumonia, pneumonia and respiratory failure). However,
only 58% of the deaths in the control cohort had an assigned
cause of death.
Discussion
Historically in Wales there has been a paucity of adult eating dis-
order services, with specialist services specifically for the treatment
of adult eating disorders being systematically set up across the
country in 2011.19 Owing to the tier service model used, these spe-
cialist services only accept the most severe and/or medically
Eating disorders, incidence, prognosis and profiling of patients
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complex cases of eating disorders among adults. Less severe cases of
eating disorders among adults and most children and adolescents
with eating disorders are seen in community general mental
health services. The study finds the majority of eating disorder
cases are seen by GPs and, despite the low incidence, they may
require more resources and expertise to treat the disorder
Diagnosed with
an eating disorder
Read codes ICD-10 codes
GP data
Anorexia nervosa
30%
Total Male Female
Bulimia nervosa
32%
Other eating disorder
38%
Total
100%
Anorexia nervosa
51%
Bulimia nervosa
21%
Other eating disorder
28%
Total
100%
Anorexia nervosa
31%
Bulimia nervosa
31%
Other eating disorder
38%
Total
100%
4356
100%
4584
100%
5364
100%
283
6%
257
6%
660
12%
4073
94%
4327
94%
4704
88%
14 304
100%
1200
8%
13 104
92%
In-patient hospital admissions
Total Male Female
1417
100%
101
7%
1316
93%
574
100%
38
7%
536
93%
762
100%
129
17%
633
83%
2753
100%
268
10%
2485
90%
Combined cohort
Total Male Female
4870
100%
328
7%
4542
93%
4836
100%
279
6%
4557
94%
5852
100%
756
13%
5096
87%
15 558
100%
1363
9%
14 195
91%
Cases matched by gender on
diagnosis date ±30 days to controls
8998 patients with eating disorders lost
2 years before diagnosis
Match each case to
four controls
Both patients with eating disorders
and controls have continuous GP
registrations in SAIL 2 years before
diagnosis or 3 years after diagnosis,
allowing for up to 30 days of gaps
between GP registrations
9781 patients with eating disorders lost
3 years after diagnosis
Patients Controls
Male
10%
551 2204
Female
90%
5226 20 904
23 1085777
Total
100%
Patients Controls
Male
10%
682 2728
23 5125878
6560 26 240
Female
90%
Total
100%
Fig. 1 Flow chart of data preparation.
GP, general practitioner; SAIL, Secure Anonymised Information Linkage.
Demmler et al
4
successfully. An average GP practice will see between one and three
new cases of eating disorders in young people every year, and these
patients will show higher rates of presentation with gastrointestinal,
dietetic and mental health disorders (personality disorders, alcohol
dependence syndrome and depressive disorders) and these condi-
tions both precede and continue for at least 3 years after diagnosis.
The death rate is highest for those with anorexia nervosa at approxi-
mately 1.7 per 1000 person-years at follow-up (see Table 1).
However, this is far less than previously published figures of 5.1
deaths per 1000 person-years.10 As an observational study, we are
unable to speculate about why the overall mortality is much lower
than reported elsewhere, nor of the reasoning behind the primary
causes of death that are reported in the death certificates. In addition,
in recent years we find the incidence of new diagnoses of eating dis-
orders is levelling off or showing a trend to declining. This is largely
consistent with a recent epidemiological study in the Netherlands.20
The incidence rate found in our study of 24 per 100 000 people in
2003/04 compares with a recent article from England, using the
Clinical Practice Research Datalink with 400 GP practices, which
found an overall crude incidence rate of 33 (95% CI 30.7–35.3) per
100 000 in 2000 and 36 (95% CI 34.4–39.2) per 100 000 in 2009.
There appears to be a levelling off/ decrease in diagnoses in the GP
data, although this is not reflecting referral trends in eating disorder
specialist services. This finding of no increase in diagnoses at the GP
level is consistent with recent reports that the population incidence of
bulimia nervosa appears to be decreasing and the incidence of
anorexia nervosa is plateauing.20,21 The increasing eating disorder
referrals from GP in the data echo anecdotal reports from across
the UK that referrals for both adult and child and adolescent specialist
eating disorder services are increasing year upon year. The increasing
referral rates may reflect increasing awareness among GP of eating
disorders, alongside awareness of expansion of specialist eating dis-
order services across Wales and the rest of the UK.
The identification of those with eating disorders is often difficult
and delayed.22 The increased prescription of central nervous system
drugs (which includes psychiatric medication) and dietetic drugs in
the 2 years before first diagnosis of an eating disorder suggests that
these individuals were already presenting to their GPs in this time
with weight loss and psychiatric symptoms well before first diagno-
sis. Other diagnoses of anxiety, neurotic disorders, acute reaction to
stress and depressive disorder which were found in significantly
more patients with eating disorders in our data sets, are also
common comorbidities with eating disorders.23
There are changes pre- and post-diagnosis in increased pre-
scription for antipsychotic medication, increased prescription for
antidepressant medication and increase in nondependent misuse
of drugs. Antipsychotics have been reported to play an important
role in managing eating disorder,24 and antidepressants were
found to be prescribed to nearby a third of patients with eating dis-
orders in another study.25 Alcohol26 and drug misuse27 have previ-
ously been reported as frequent comorbidities in eating disorders.
Alcohol misuse has also been shown to be an important predictor
of mortality in anorexia nervosa.28,29
Limitations
Using a hierarchical diagnosis system for the whole study period
means that we can only make statements about the top eating dis-
order category for people within the time period. This study only
reports on diagnosed eating disorders that are both known to the
healthcare practitioners and coded into patient records within the
study period; as a result we cannot estimate or report on
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Fig. 2 Incidence of eating disorders in the combined cohort and number of referrals to specialist eating disorders services over time.
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undiagnosed or pre-existing eating disorders, and so incidences are
only for clinical presentation and will always be expected to be an
underestimate of the true numbers. Furthermore, it is not possible
to report on the prevalence of eating disorders in the population
as the database does not enable us to determine recovery from a pre-
viously diagnosed eating disorder. The number of cases in the case–
control study was only 42% of the total cohort for 2 years before
diagnosis and 37% of the total for 3 years after diagnosis. The loss
of cases is mainly attributed to migration during the follow-up
period or due to limited data submission by individual GP practices.
Given the peak age of presentation of an eating disorder diagnosis
coincides with when most students go to college or university,
this may reflect movement of patients who subsequently go to uni-
versities outside Wales or patients who come into Wales for study
and then return home.
Implications and future directions
This study suggests that although the incidence of eating disorders is
relatively low (24 per 100 000 people per year) compared with some
other mental disorders, patients with eating disorders have a signifi-
cantly higher burden of morbidity and other mental health pro-
blems and thus form a considerable burden to the NHS.
Furthermore, they have significantly higher prescriptions of
a)
A: Infectious/parasitic diseases
B: Neoplasms 
C: Endocrine/nutr./metab./immun. disease
D: Blood/blood-forming organs disease
E: Mental disorders
F: Nervous system/sense organ disease
G: Circulatory system disease
H: Respiratory system disease 
J: Digestive system disease
K: Genitourinary system disease
L: Pregnancy/childbirth/puerperium
M: Skin/subcutaneous  tissue disease
N: Musculoskeletal/connective tissue
P: Congenital anomalies
R: Symptoms, signs, ill-defined conditions
S: Injury and poisoning
T: Causes of injury and poisoning
U: External causes of morbidity and mortality
Z: Unspecified conditions
b)
2 years before diagnosis
0 21 3 4 5 0 21 3 4 5
OR
2 years before diagnosis
3 years after diagnosis
OR
3 years after diagnosis
a: Gastrointestinal drugs
b: Cardiovascular drugs
c: Respiratory drugs
d: Central nervous system drugs
e: Drugs used in infections
f: Endocrine drugs
g: Obstetric/gynaecological/UTI drugs
h: Chemotherapy/immunosuppressant drugs
i: Heamatology/dietetic drugs
j: Musculoskeletal drugs
k: Eye drugs
l: ENT drugs
m: Skin drugs
n: Immunology  drugs and vaccines
C
ha
pt
er
C
ha
pt
er
o: Anaesthetic drugs
p: Appliances and reagents (dressing, etc.)
s: Stoma appliances (plasters, tape, etc.)
0 02 4
OR
6 2 4 6
OR
Fig. 3 Odds ratios for (a) diagnoses and (b) prescriptions 2 years before or 3 years after an eating disorder diagnosis. Diagnoses exclude eating
disorders. Only significant results at 95% confidence intervals with at least 10 affected cases or 40 affected controls are displayed.
Endocrine/nutr./metab./immun. disease, Endocrine, nutritional, metabolic and immunity disorders; OR, odds ratio; UTI, urinary tract infection; ENT, ear, nose and throat.
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medications for gastrointestinal, dietetic and psychiatric conditions.
This illustrates the multi-system, long-term burden of both eating
disorders and their physical and mental sequelae, as well as their
comorbidities. This underlines the need for healthcare professionals
who treat eating disorders to be prompt and skilled in their manage-
ment in the community, a point stressed by recent National Institute
for Health and Care Excellence guidance for eating disorders.30
Our findings suggest that increased diagnoses and prescriptions
begin at least 3 years before a diagnosis of an eating disorder is
made. Better identification and early interventions would greatly
reduce the multiple burdens of eating disorders in future through
better identification and early intervention.
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